Isoniazid API is a pharmaceutical-grade first-line antitubercular agent widely used in the treatment and prevention of tuberculosis (TB) caused by Mycobacterium tuberculosis. It remains one of the most effective and essential medicines recommended by the World Health Organization (WHO) for tuberculosis management.
Isoniazid works by inhibiting the synthesis of mycolic acids, which are essential components of the mycobacterial cell wall. This action disrupts bacterial cell wall formation, leading to the destruction of actively dividing tuberculosis bacteria. It is commonly used in combination with other antitubercular drugs such as Rifampicin, Pyrazinamide, and Ethambutol to reduce the development of drug resistance.
Manufactured under WHO-GMP-certified facilities, our Isoniazid API is produced using advanced pharmaceutical manufacturing technologies to ensure exceptional purity, stability, and batch-to-batch consistency. Every batch undergoes rigorous quality testing and is supplied with Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), Technical Data Sheet (TDS), and complete regulatory documentation.
Isoniazid API is used in oral pharmaceutical formulations for the treatment and prevention of tuberculosis caused by Mycobacterium tuberculosis.
Isoniazid inhibits the synthesis of mycolic acids, essential components of the mycobacterial cell wall, leading to bacterial cell death.
Yes. We provide CoA, MSDS, Technical Data Sheet (TDS), Product Specifications, and complete regulatory documentation with every shipment.
Yes. We supply Isoniazid API in commercial quantities with worldwide export support and customized packaging.
Get Bulk Quote via WhatsApp